Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Results of the TACT2 and BEATRICE breast cancer trials
Prof David Cameron – Edinburgh University, UK
Results of the TACT2 and BEATRICE breast cancer trials ( Prof David Cameron – Edinburgh University, UK )
16 Dec 2012
Influence of low penetrant factors on overall cancer risk
Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge...
Influence of low penetrant factors on overall cancer risk ( Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge University, UK )
16 Dec 2012
Diverse genetic alterations found in triple-negative breast cancers after...
Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA
Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo ( Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA )
16 Dec 2012
A new oestrogen receptor protein target
Dr Jason Carroll – University of Cambridge, UK
A new oestrogen receptor protein target ( Dr Jason Carroll – University of Cambridge, UK )
16 Dec 2012
Ethical issues associated with genomic sequencing
Dr James Evans – University of North Carolina, Chapel Hill, USA
Ethical issues associated with genomic sequencing ( Dr James Evans – University of North Carolina, Chapel Hill, USA )
16 Dec 2012
Links between EGFR/HER1 signalling and trastuzumab efficacy
Dr David Rimm – Yale University, New Haven, USA
Links between EGFR/HER1 signalling and trastuzumab efficacy ( Dr David Rimm – Yale University, New Haven, USA )
16 Dec 2012
Use of FDG PET imaging
Dr David Mankoff - University of Pennsylvania, Philadelphia
Use of FDG PET imaging ( Dr David Mankoff - University of Pennsylvania, Philadelphia )
16 Dec 2012
Effects of obesity in breast cancer patients
Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012
The AZURE translational study
Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012
Diagnosis of blood cancer after a breast cancer diagnosis
Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012
HDAC inhibition sensitises triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
13 Dec 2012
A need for clarity in clinical trial end points
Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
A need for clarity in clinical trial end points ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
13 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation